Agency
Mount Auburn Hospital
Mount Auburn Hospital was paid $144K by Medicaid between Jan 2020 and May 2020, across 71 billing codes. Its largest line is 99285, emergency room visit (most serious) — 31% of everything it billed.
33Billing provider infoMOUNT AUBURN HOSPITAL
WATERTOWN, MA 02472
WATERTOWN, MA 02472
33aNPI1902880016assigned 12/01/2005
33bProvider typeHome Health Agency
28Total paid$144K
24GClaims5,485
24DCodes billed71
24AFirst – last monthJan 2020 – May 2020
Compared with peers
Next to other Home Health Agency providers in Massachusetts
Rank by total paid#234 of 299
Median peer was paid$2.39M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SMITH, BRIAN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 5,485 | $144K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 31% | 220 | 205 | $45K |
| 96361 | Intravenous infusion, hydration; each additional hour | 13% | 38 | 29 | $18K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 99 | 89 | $17K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.5% | 64 | 29 | $6K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.4% | 34 | 31 | $6K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2.7% | 18 | 17 | $4K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2.4% | 28 | 28 | $4K |
| 80053 | Comprehensive metabolic panel | 2.4% | 278 | 258 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.0% | 91 | 91 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 416 | 364 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.0% | 87 | 87 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.7% | 156 | 156 | $2K |
59 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.6% | 52 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.5% | 215 | $2K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 13 | $2K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.2% | 70 | $2K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 85 | $2K |
| 99219 | 1.0% | 260 | $1K | |
| 87449 | <1% | 61 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 31 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 147 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 38 | $1K |
| 80061 | Lipid panel | <1% | 206 | $1K |
| 80050 | General health panel | <1% | 58 | $982.52 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 49 | $880.20 |
| 85027 | <1% | 146 | $861.40 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 36 | $790.92 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 44 | $786.30 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 101 | $699.20 |
| 82607 | <1% | 44 | $605.00 | |
| 81001 | <1% | 216 | $603.20 | |
| 86803 | <1% | 39 | $507.39 | |
| 82728 | <1% | 38 | $472.34 | |
| 87070 | <1% | 54 | $424.44 | |
| 84484 | <1% | 32 | $386.82 | |
| 84703 | <1% | 55 | $363.58 | |
| 87808 | <1% | 28 | $316.40 | |
| 84439 | <1% | 37 | $304.14 | |
| 83550 | <1% | 33 | $263.01 | |
| 83690 | <1% | 46 | $257.89 | |
| 87102 | <1% | 32 | $245.44 | |
| 87205 | <1% | 34 | $229.51 | |
| 83540 | <1% | 34 | $200.60 | |
| 87340 | <1% | 18 | $169.56 | |
| 80076 | <1% | 27 | $148.55 | |
| 83735 | <1% | 19 | $116.09 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 68 | $115.40 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 60 | $115.40 |
| J2704 | Injection, propofol, 10 mg | <1% | 53 | $115.40 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 71 | $115.40 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 21 | $115.40 |
| 86140 | <1% | 19 | $89.68 | |
| 87077 | <1% | 12 | $88.44 | |
| 82248 | <1% | 250 | $80.89 | |
| 82043 | <1% | 16 | $79.20 | |
| 86592 | <1% | 20 | $77.80 | |
| 81025 | <1% | 12 | $76.32 | |
| 85652 | <1% | 19 | $46.74 | |
| 85610 | <1% | 12 | $42.96 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 121 | $27.23 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 40 | $0.00 |
| 84460 | 0% | 12 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 49 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 510 | $0.00 |
| 82962 | 0% | 18 | $0.00 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 76 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 13 | $0.00 |
| 76830 | Ultrasound, transvaginal | 0% | 18 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 38 | $0.00 |
| 83615 | 0% | 13 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, BRIAN (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.